Previous 10 | Next 10 |
2024-05-31 02:45:30 ET Summary Stryker's first quarter results were strong, with profit margins increasing and solid procedure volumes supporting growth. The company's capital order book remains strong, which, along with new product launches, should help to support growth as pande...
2024-05-30 08:00:06 ET Shagun Singh from RBC Capital issued a price target of $140.00 for ZBH on 2024-05-30 06:24:00. The adjusted price target was set to $140.00. At the time of the announcement, ZBH was trading at $115.14. The overall price target consensus is at $142....
Zimmer Biomet Outlines Strategy to Deliver Above Market Growth at 2024 Investor Day PR Newswire Presents Path for Compelling and Durable Topline Growth, Improved Operational Profitability and Increased Free Cash Flow Generation Details New Capital Allocation Priorities...
2024-05-28 07:30:06 ET BTIG analyst issues BUY recommendation for ZBH on May 28, 2024 05:32AM ET. The previous analyst recommendation was Buy. ZBH was trading at $116.41 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst rec...
2024-05-24 15:00:53 ET More on the markets S&P 500: It Is All About Liquidity SPY: Time To Be Contrarian And Underweight SPY ETF: Momentum Is In The Cards Stocks have more room to run - Invesco's Kristina Hooper Big bear Mike Wilson changes tune a...
2024-05-21 16:34:03 ET More on Zimmer Biomet Zimmer Biomet Holdings: Moving Along Zimmer Biomet Holdings, Inc. (ZBH) Q1 2024 Earnings Call Transcript Zimmer Biomet Q1 2024 Earnings Preview Zimmer Biomet wins FDA clearance for ROSA Shoulder System Seek...
Zimmer Biomet Announces 2024 Investor Day PR Newswire WARSAW, Ind. , May 20, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it will host an Investor Day on Wednesday, May 29, 20...
(NewsDirect) Regenerative medicine is revolutionizing healthcare. It encompasses a range of cutting-edge therapies aimed at repairing or replacing damaged tissues and organs, offering tangible solutions rather than mere symptom management. With a global market projected to surge from USD 29.4...
2024-05-17 15:19:41 ET Summary Zimmer Biomet Holdings, Inc.'s growth has been modest, as investors are concerned about the rise of GLP-1 drugs, raising concerns about future growth. The company's revenue stagnated after spinning off its dental and spine operations, but recently ha...
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2024 PR Newswire WARSAW, Ind. , May 13, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors ha...
News, Short Squeeze, Breakout and More Instantly...
Zimmer Biomet Holdings Inc. Company Name:
ZBH Stock Symbol:
NYSE Market:
Zimmer Biomet Holdings Inc. Website:
2024-07-15 16:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2024 Financial Results PR Newswire WARSAW, Ind. , July 8, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter earnings conference call will ...
Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors PR Newswire WARSAW, Ind. , June 20, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Devdatt "Dev" Kurdika...